EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nervonic acid confers neuroprotection in a zebrafish model of diabetic neuropathy by promoting myelin repair and metabolic modulation

Huan Ge, Mingzhu Dai, Qinwen Wang, Bingbing Cao, Ximin Zhu, Jie Guo, Tao Zhang, Shasha Wang, Yiqiao Xu, Lushan Yu

Frontiers in Pharmacology · 18.02.2026 · 17

DOI: 10.3389/fphar.2026.1721486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.02.2026. Verfasst von Huan Ge und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic neuropathy (DN) is one of the most common and debilitating complications of type 2 diabetes mellitus (T2DM), yet effective therapeutic strategies remain limited. Nervonic acid (NA) is recognized for its neuroprotective and anti-inflammatory properties. However, its role in DN has not been fully elucidated. In this study, we investigated the protective effects of NA against T2DM-induced DN using a zebrafish model and explored the underlying molecular mechanisms.

Methods

T2DM was induced in zebrafish larvae through a high-fat, high-glucose diet combined with a low dose of streptozotocin. Larvae were subsequently treated with NA at concentrations of 125, 250, or 500 μg/mL. Motor function, myelin integrity, neutrophil infiltration, and reactive oxygen species (ROS) levels were evaluated using fluorescence imaging and histological staining. Gene expression analysis was performed by quantitative real-time PCR. Metabolomics coupled with KEGG enrichment analysis was applied to identify NA-regulated metabolic pathways.

Results

NA significantly preserved myelin integrity, reduced neutrophil infiltration, and lowered ROS levels in DN zebrafish. Expression of myelin-related genes ( mbpa and mpz ) was upregulated, while pro-inflammatory cytokines were downregulated following NA treatment. Metabolomic profiling revealed that NA reversed diabetes-associated dysregulation in purine metabolism, energy metabolism, vitamin B6 pathways, and redox homeostasis. Key metabolites including guanosine monophosphate, adenosine triphosphate, pyridoxal 5′-phosphate, and L-glutathione were markedly restored toward normal levels.

Discussion

These findings demonstrate that NA confers robust neuroprotection in DN by alleviating inflammation and oxidative stress, preserving neuronal structure and function, and reprogramming key metabolic pathways.

Schlagwörter

Stichwörter der Autor:innen

diabetes neuropathymetabolomicsmyelin repairnervonic acidneuroprotectionoxidative stress

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Hunter BioInsight Technology, Inc., Hangzhou, China.
  • Hunter Biotechnology, Inc., Hangzhou, China.
  • Zhejiang Provincial Engineering Research Center for Innovative Small-Molecule Drugs, Jinhua, China.

Zitieren

APA

Ge, H., Dai, M., Wang, Q., Cao, B., Zhu, X., Guo, J., Zhang, T., Wang, S., Xu, Y., & Yu, L. (2026). Nervonic acid confers neuroprotection in a zebrafish model of diabetic neuropathy by promoting myelin repair and metabolic modulation. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1721486

Vancouver

Ge H, Dai M, Wang Q, Cao B, Zhu X, Guo J, et al. Nervonic acid confers neuroprotection in a zebrafish model of diabetic neuropathy by promoting myelin repair and metabolic modulation. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1721486

BibTeX
@article{Ge2026,
  author = {Ge, Huan and Dai, Mingzhu and Wang, Qinwen and Cao, Bingbing and Zhu, Ximin and Guo, Jie and Zhang, Tao and Wang, Shasha and Xu, Yiqiao and Yu, Lushan},
  title = {Nervonic acid confers neuroprotection in a zebrafish model of diabetic neuropathy by promoting myelin repair and metabolic modulation},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1721486}
}
Kostenlos starten →